Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6417-6427
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6417
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6417
Patient | Age/gender | Symptoms | Eosinophil (%) | HB (g/L) | CRP (mg/dL) | Albumin (g/L) | IgE (IU/mL) | HPF | Initial treatment | Relapse | Relapse treatment | ||
Duodenum | Stomach | Ileum | |||||||||||
1 | 7/male | Vomiting | 0.59 | 111 | < 1 | 44 | 31 | 10 | 40 | Lansoprazole | N | ||
2 | 9/male | Loss of appetite, difficulty swallowing, foreign-body sensation in pharynx | 0.76 | 119 | 4.3 | 43.7 | 58 | 36 | 10 | Methylprednisolone. Montelukast | N | ||
3 | 12/male | Abdominal pain | 1.00 | 142 | 2 | 43 | 156 | 30 | 4 | 66 | Methylprednisolone | N | |
4 | 7/male | Abdominal pain, vomiting | 1.02 | 137 | < 1 | 43 | 54 | 25 | Y | Montelukast | |||
5 | 13/male | Abdominal pain, vomiting | 1.14 | 135 | 32 | 41.3 | 624 | 21 | 21 | Methylprednisolone | N | ||
6 | 9/male | Abdominal pain, vomiting | 1.19 | 121 | < 1 | 43.1 | 37 | 30 | 28 | Methylprednisolone. Montelukast | N | ||
7 | 3/male | Abdominal pain | 1.24 | 104 | 24 | 27 | 21.9 | 40 | 10 | Methylprednisolone. Montelukast | N | ||
9 | 7/female | Abdominal pain, vomiting | 1.63 | 135 | 21.5 | 37.6 | 64 | 40 | 10 | Lansoprazole. Montelukast | N | ||
10 | 11/male | Abdominal pain | 2.73 | 141 | < 1 | 47.4 | 112 | 26 | 9 | Methylprednisolone. Montelukast | N | ||
11 | 10/female | Abdominal pain | 3.25 | 132 | 3.7 | 41.8 | 35 | 8 | 22 | Methylprednisolone | N | ||
12 | 10/male | Abdominal pain, diarrhea, nausea, burping | 4.88 | 110 | 6 | 50 | 1113 | 90 | 5 | Montelukast | N | ||
13 | 11/male | Abdominal pain, vomiting | 4.95 | 132 | 4.09 | 41 | 121 | 53 | 8 | Methylprednisolone. Montelukast | N | ||
14 | 13/male | Abdominal pain, vomiting | 5.12 | 151 | 2.78 | 46.5 | 1001 | 21 | 6 | Lansoprazole. Montelukast | N | ||
15 | 13/male | Abdominal pain, nausea, acid regurgitation | 8.38 | 121 | 11.8 | 37 | 26 | 28 | 4 | Montelukast | N | ||
16 | 11/female | Abdominal pain | 9.20 | 127 | 39 | 48 | 317 | 60 | 70 | Methylprednisolone. Montelukast | N | ||
17 | 11/male | Abdominal pain, black stool | 10.63 | 123 | < 1 | 37 | 155 | 40 | 60 | Lansoprazole. Montelukast | N | ||
18 | 14/male | Vomiting, diarrhea | 11.83 | 155 | < 1 | 45 | 54 | 30 | 3 | 32 | Methylprednisolone. Montelukast | N | |
19 | 3/male | Periorbital edema, limb swelling | 14.66 | 92 | 2.25 | 17 | 337 | 30 | 200 | Methylprednisolone. Budesonide | N | ||
20 | 10/male | Abdominal pain | 14.89 | 122 | 3.67 | 41.4 | 80 | 48 | Methylprednisolone | Y | Methylprednisolone | ||
21 | 5/male | Periorbital edema, limb swelling | 41.63 | 116 | 13.7 | 21.7 | 649 | 400 | 70 | Methylprednisolone. Montelukast | Y | Methylprednisolone. Budesonide | |
22 | 7/female | Abdominal pain, vomiting, diarrhea | 58.50 | 125 | 1.88 | 40.9 | 331 | 50 | 120 | Methylprednisolone. Budesonide | N |
- Citation: Chen Y, Sun M. Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series. World J Clin Cases 2022; 10(19): 6417-6427
- URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6417.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i19.6417